Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Cost-effectiveness models have suggested that some of the newer agents may be of relatively lower clinical utility based on high cost and moderate glycemic effect (27)
Timing: Consider when the rash appeared in relation to when you started taking semaglutide
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
Approved as a once-weekly GLP-1 receptor agonist for chronic weight management in adults with obesity or overweight-related health conditions, Wegovy entered the India Semaglutide market ahead of its patent expiry to counter rising competition from Eli Lillys Mounjaro
Kara, et al., 'Effects of Retatrutide on Learning and Memory in Streptozotocin-Induced Diabetic Rats', bioRxiv , Jan
Whether youre managing type 2 diabetes or looking for weight loss support, your primary care or obesity medicine provider can help you find the right path forward
